Newsfeeds - Spark Newswire

2 minute read

GlycoMimetics Announces New Uproleselan Clinical Data In Both Frontline Unfit And Treated Secondary Acute Myeloid Leukemia Presented At ASH Annual Meeting

Today, 3:46 PM

GlycoMimetics, Inc. (NASDAQ:GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced results from two

GLYC

6 minute read

Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday

By Lisa Levin

Today, 3:46 PM

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.

3 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 3:46 PM

Gainers

AIRS

8 minute read

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday

By Lisa Levin

Today, 3:46 PM

Gainers

$APE

1 minute read

GlycoMimetics Q3 EPS $(0.16) Beats $(0.26) Estimate

By Benzinga Newsdesk

Today, 3:46 PM

GlycoMimetics (NASDAQ:GLYC) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.26) by 38.46 percent. This is a 52.94 percent increase over losses of $(0.34) per share from the

GLYC